Mepolizumab for chronic rhinosinusitis with nasal polyps

Guy G. Brusselle, Philippe Gevaert

Research output: Contribution to journal › Comment/Letter to the editor › Popular

2 Citations (Scopus)

Original language	English
Pages (from-to)	1081-1082
Number of pages	2
Journal	The Lancet Respiratory Medicine
Volume	9
Issue number	10
DOIs	https://doi.org/10.1016/S2213-2600(21)00133-8
Publication status	Published - 1 Oct 2021

Access to Document

@article{3ffe88dbe21f4c2ba37cfc7fcbd47f3b,

title = "Mepolizumab for chronic rhinosinusitis with nasal polyps",

author = "Brusselle, {Guy G.} and Philippe Gevaert",

year = "2021",

month = oct,

day = "1",

doi = "10.1016/S2213-2600(21)00133-8",

language = "English",

volume = "9",

pages = "1081--1082",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Ltd.",

number = "10",

}

TY - JOUR

T1 - Mepolizumab for chronic rhinosinusitis with nasal polyps

AU - Brusselle, Guy G.

AU - Gevaert, Philippe

PY - 2021/10/1

Y1 - 2021/10/1

UR - http://www.scopus.com/inward/record.url?scp=85106666039&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(21)00133-8

DO - 10.1016/S2213-2600(21)00133-8

M3 - Comment/Letter to the editor

C2 - 33872589

AN - SCOPUS:85106666039

VL - 9

SP - 1081

EP - 1082

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

SN - 2213-2600

IS - 10

ER -